Business Models for Pharmacogenetics
Source: SourceOECD Social Issues/Migration/Health, Volume 2009, Number 21, November 2009 , pp. 52-67(16)
Abstract:This chapter discusses the challenges posed by pharmacogenetics to established "big pharma" business models in the pharmaceutical and diagnostics and device industries. It considers the viability of current business models and the financial incentives of different types of firms.
Document Type: Review Article
Publication date: November 1, 2009